Preparation Of A P2X3 Antagonist - EP4387959
The patent EP4387959 was granted to Glaxosmithkline on Jul 2, 2025. The application was originally filed on Aug 16, 2022. The patent is currently recorded with a legal status of "Pending".
EP4387959
- Filing Date
- Aug 16, 2022
- Status
- Pending
- Grant Date
- Jul 2, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents